Atlas Trials

PD-1

27 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch PD-1

RecordFirmDate
Biomarker Analysis of Tislelizumab Combined With Chemotherapy for Perioperative Treatment of G/GEJ Adenocarcinoma (NCT05508399)Xijing Hospital2022-07-18
PD-1 Antibody for Reactive EBV After BMT (NCT04690036)Beijing Friendship Hospital2021-07-01
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors (NCT04615988)Icahn School of Medicine at Mount Sinai2021-06-09
Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer (NCT04906044)The First Hospital of Jilin University2021-06-01
A Multicenter Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinoma：The POTENTIAL Study (NCT04814069)Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University2021-04-01
Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction (NCT06250894)Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2021-03-30
Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma (NCT04778956)Sun Yat-sen University2021-03-03
PD-1 Combined With Dasatinib for as Third-line Treatment for ARID1A Mutation Advanced NSCLC (NCT04284202)The Affiliated Hospital of Qingdao University2020-03-01
Genetic Mutation in Epithelial Ovarian Cancer (NCT04191252)Lei Li2019-12-19
Genetic Mutation in Recurrent Cervical Cancer (NCT04191226)Lei Li2019-12-19
Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ (NCT04061928)Peking University2019-08-26

Track PD-1 automatically

Every clearance here is in the API, with alerts when new ones post.